In a cohort of patients with renal cell carcinoma, TCF1+/CD8+ cells preferentially co‐localised to areas with clusters of MHC class II‐expressing cells, whereas TCF1−/CD8+ cells followed a more diffuse distribution throughout the tumour. This evidence concerns the gene CD8A and neoplasm.